Jun 02, 2021 / 07:00PM GMT
Matthew Stanton - Jefferies LLC - Analyst
Good afternoon. Welcome to the Day 2 of the Jefferies Global Healthcare Conference. My name is Matt Stanton. I'm a member of the tools and diagnostics team here at Jefferies. It's my pleasure to have Fluidigm with us here at the conference again this year.
Joining us from the team we have President and CEO, Chris Linthwaite, as well as CFO, Vikram Jog. Gentlemen, thanks for joining us today.
Chris Linthwaite - Fluidigm Corp. - President and CEO
Hi, Matt, thank you for including us and just thrilled to be here at Jefferies Healthcare conference. I appreciate the opportunity to present.
Vikram Jog - Fluidigm Corp. - CFO
Yes, great to be here.
Questions and Answers:
Matthew Stanton - Jefferies LLC - AnalystSo, I guess, Chris, to kick it off, there's been a lot of debate (inaudible) within the analytical and tools space, focused on areas like multi-omics, proteomics, spatial-omics, seen a number of recent IPOs and SPACs